Use of hospitalisation history (lookback) to determine prevalence of chronic diseases: impact on modelling of risk factors for haemorrhage in pregnancy
© Chen et al; licensee BioMed Central Ltd. 2011
Received: 5 October 2010
Accepted: 17 May 2011
Published: 17 May 2011
Concern about the completeness of comorbidity information in hospital records has been raised as a limitation of using hospital discharge data for research. The aim of this study is to assess the impact of additional comorbidity information from prior hospital admissions on estimation of prevalence and modelling of risk factors for obstetric haemorrhage.
A range of chronic disease prevalence for 53,438 women who had their first birth in New South Wales (NSW), Australia, 2005-2006, were ascertained for up to five years prior to the birth admission (for pregnancy, 2-, 3-, 4- and 5-year periods) and obstetric haemorrhage was identified from maternal hospital records for 2005 and 2006.
The ascertainment of chronic disease prevalence increased with increasing length of lookback. However, the rate of the increase was slower after 2 to 3 years than for the more recent periods. The effect size of chronic diseases on obstetric haemorrhage risk decreased with the increased case ascertainment associated with longer lookback. Furthermore, longer lookback did not improve the predictive capacity (C-statistic: 0.624) of a model that was based only on the birth admission records.
Longer ascertainment periods resulted in improved identification of chronic disease history among pregnant women, but the additional information from prior admissions did little to improve the modelling of risk factors for obstetric haemorrhage.
The use of population health data for health and health outcomes research is increasing. These routinely collected data may be administrative, surveillance, registry or vital statistics collections and have the common feature of including information on an entire population. However, concerns about the completeness of comorbidity information in the admission of interest (index record) have been raised as a limitation of using hospital discharge data for research . One reason that comorbidity information is under-ascertained from hospital records is that only diagnoses affecting the current admission are required to be coded in the discharge summary, so unrelated chronic illnesses may not be recorded . However, through record linkage it is possible to evaluate a patient's hospitalisation history in detail. Records belonging to the same individual can increasingly be longitudinally linked. The term that refers to identifying disease prevalence from health records that precede the record or event of interest is 'lookback' .
Using a longer lookback period for ascertaining a condition is likely to result in a higher proportion of subjects with the condition, but the effect of the condition may be reduced because the severity of the condition can vary depending on how recently it was identified . Few studies have assessed the impacts of different lookback periods on ascertaining comorbidities, and almost all focused on the predictive performance of a comorbidity score in modelling of in-hospital or post-hospital mortality or readmission [3, 5–8]. Little is known about the most appropriate lookback period for ascertaining comorbidities with regard to disease prevalence and risk estimation, predictive ability and statistical modelling of other outcomes. This is especially true in pregnancy which usually occurs among women who are relatively young and healthy. In Australia, 14% of female hospitalizations are related to pregnancy and childbirth. To date, lookback studies have been limited to older populations and the utility of the approach in pregnancy is unknown.
Worldwide, obstetric haemorrhage is a leading cause of maternal mortality and accounts for about 25% of all maternal deaths . Increased rates of haemorrhage following childbirth have been observed in recent years in Australia, Canada, USA and Scotland . Risk factors for obstetric haemorrhage include chronic diseases, advanced maternal age, obesity, cesarean section, multiple births, and induction and augmentation of labor [11–13]. Obstetric haemorrhage is therefore a suitable outcome to use for examining the effect of different lookback periods on ascertainment of risk factors and their prediction of subsequent outcome. In this study, we used longitudinally linked hospital discharge records to (1) assess impacts of different lookback periods on ascertainment of chronic disease history in pregnant women and (2) examine effects of increased ascertainment on modelling of risk factors for obstetric haemorrhage.
Study population and data sources
In the State of New South Wales (NSW), Australia, comprehensively linked perinatal population data were available from 1 July, 2000 to 31 December, 2006. Details of the record linkage were reported in a previous study . For the current study we selected a population of pregnant women with five years of lookback and focused on women in their first pregnancy. Women with a previous pregnancy would have prior maternal admissions and might therefore have more opportunities for identification of chronic diseases in hospital data than women without a previous pregnancy. Study subjects included 55,002 women who had their first birth in NSW during 1 July, 2005 to 31 December, 2006. These women were identified from the NSW Midwives Data Collection ('birth data'). The birth data contain information on all births in NSW, including number of previous births, maternal health (including pre-existing hypertension), pregnancy, labour, delivery and perinatal outcomes. The birth data include information on live births or stillbirths of at least 20 weeks gestation or at least 400 grams birth weight.
Ascertainment of diseases
We selected chronic diseases including cardiac diseases, chronic renal disease, asthma/chronic obstructive pulmonary disease (COPD), psychiatric disorders, pre-existing hypertension, pre-existing diabetes, thyroid disorders and autoimmune diseases, for the study. The autoimmune diseases include Crohn's disease, ulcerative colitis, lupus, idiopathic, thrombocytopenic purpura, multiple sclerosis, psoriasis, autoimmune thyroiditis, rheumatoid diseases, Coeliac disease, vasculitis, pernicious anemia, myasthenia gravis, autoimmune hepatitis, ankylosing spondylitis, polymyositis and primary biliary cirrhosis. There is some evidence suggesting increased risk of obstetric haemorrhage associated with cardiac disease, pre-existing hypertension, asthma and thyroid disorders [11, 16–18]. Based on biological plausibility, and since it is not clear that others have investigated potential associations with obstetric haemorrhage, renal disease, psychiatric disorders, diabetes and autoimmune diseases were also included as potential risk factors for haemorrhage. Given that there are relatively few population-based studies of risk factors for obstetric haemorrhage and that the chronic diseases are relatively rare among pregnant women, our large sample of pregnancies represented an ideal opportunity to investigate potential influence of other chronic diseases on haemorrhage risk. These diseases were chosen because their chronic nature means that they would still be present at the time of the birth regardless of the lookback period chosen.
ICD10-AM diagnose and procedure codes for the eight chronic diseases.
Diagnoses: I00-02, I05-09, I10-I15, I20-25, I26-28, I30-52, O90.3, Q20-Q25 (when assessing the birth admission records codes such as I21, I24, I30, I33, I40, I46 and I50 were excluded)
Procedure: 38603-00, 38600-00, 38256-00, 38256-01, 38256-02, 38278-00, 38278-01, 38284-00, 90202-00, 38470-00, 38473-00, 38281-01, 38281-02, 38281-03, 38281-04, 38281-05, 38281-06, 38281-07, 38281-07, 38281-08, 38281-09, 38281-10, 38281-00, 38278-02, 38456-07, 90203-00, 38284-01, 90219-00, 38281-11, 38281-12, 38212-00, 38209-00, 38200-00, 38203-00, 38206-00, 35324-00, 35315-00, 35315-01, 35304-01, 35305-00, 35304-00, 35305-01, 35310-00, 35310-01, 35310-03, 35310-04, 35310-02, 35310-05 (assessed only on hospital records before the birth admission)
Chronic kidney disease
Diagnoses: E10.2, E11.2, E12.2, E13.2, E14.2, I12-13, I15.0, I15.1, N00-08, N11-12, N14-16, N18-19, N25-28, N39.1, N39.2, Q60-63, T82.4, T86.1, Z49, Z94.0, Z99.2
Procedure: 36561-00, 36503-00, 36503-01, 13100-06, 13100-07, 13100-08, 13100-00 (assessed only on hospital records before the birth admission)
Asthma/Chronic obstructive pulmonary disease
Diagnoses: J40-J47, J98, R05
Diagnoses: F20-F25, F28-F34, F38, F39, F53.1
Diagnoses: O10, O11, I10-I15 or chronic hypertension* in birth data
Diagnoses: O24.0-O24.3, E10-E14 (excluded records that were also coded with O24.4)
Diagnoses: E00-E07, E89.0, O90.5
Procedure: 30075-03, 30094-10, 30296-00, 30297-00, 30297-01, 30306-00, 30308-00, 30309-00, 30310-00, 36503-01, 90041-00, 90046-00, 90046-01, 90047-00, 90047-01, 90047-02 (assessed only on hospital records before the birth admission)
Diagnoses: K50, K51, M32, L93, D69.3, G35, L40, E06.3, M05, M06, K90.0, I77.6, I80, L95, M30, M31, D51.0, G70.0, K75.4, M08.1, M45, M33.2, K74.3, M33.0, M33.1
Diagnoses: O72, O67, O46.0, O44.1, O43.2, Z51.3, D62
Procedure: 13706-01, 13706-02, 13706-03, 92061-00, 92062-00, 90482-00, 90483-00
In this study, obstetric haemorrhage (refer to as 'haemorrhage') was identified from maternal hospital records for the birth admission and any associated transfer to another hospital prior to discharge home. A case of haemorrhage was determined if a record had any diagnosis code for postpartum haemorrhage (O72), intrapartum haemorrhage (O67), placenta previa with haemorrhage (O44.1), antepartum haemorrhage (O46.0), morbidly adherent placenta (O43.2), transfusion (Z51.3) or acute post-haemorrhage anaemia (D62); any procedure code for transfusions (13706-01,13706-02,13706-03,92061-00 or 92062-00) or in case of vaginal birth any procedure code for manual removal of placenta (90482-00 or 90483-00).
The proportion of women with the selected chronic disease was calculated for different lengths of lookback, with the longer lookback periods including all conditions reported in the shorter periods: 'Birth' - at birth admission (day 0), 'Pregnancy' - from day 0 back to the estimated 1st day of pregnancy, '2 years' - from day 0 back to 2 years, '3 years' - from day 0 back to 3 years, '4 years' - from day 0 back to 4 years and '5 years' - from day 0 back to 5 years. The first day of pregnancy was estimated by baby's date of birth minus 7 × gestation age (ranged from 18 to 44 weeks) that was recorded in the birth record. Potential risk factors for obstetric haemorrhage such as type of hospital, baby's gender, birth weight, multiple birth, gestational age, maternal age and combination of onset of labour and mode of delivery were obtained from the birth record where they are reliably reported .
Logistic regression was employed to determine the effect size (odds ratio) of a potential risk factor on haemorrhage after adjusting for maternal age. In the selection of independent risk factors, age was always retained in the model and a backwards elimination approach was used to progressively remove the least significant term until all terms remaining were significant (P < 0.05, two-sided). The capacity of a model to predict haemorrhage was evaluated using the area under the receiver-operating characteristic (ROC) curve (C-statistic), with values of 1.0 representing perfect ability and 0.5 indicating no better ability than chance. For comparing correlated C-statistics, we used %roc SAS® macro  (a nonparametric approach based on generalized U-Statistics ).
Numbers of women and hospital records for each ascertainment period
No. (%) of women
(N = 53,438)
No. (%) of hospital records
(N = 113,478)
At birth admission
Estimated day preceding pregnancy to <2 years prior to delivery
2 to <3 years prior to delivery
3 to <4 years prior to delivery
4 to <5 years prior to delivery
Cumulative frequency and relative frequency of cases ascertained at different lookback periods and the prevalence of diseases for the 53,438 women by disease type
% of total cases
Chronic renal disease
% of total cases
% of total cases
% of total cases
% of total cases
% of total cases
% of total cases
% of total cases
Age-adjusted&odds ratio (OR) for potential predictors of obstetric haemorrhage for different lookback periods
Type of diseases
OR (95% CI)
Chronic renal disease
OR (95% CI)
OR (95% CI)
OR (95% CI)
OR (95% CI)
OR (95% CI)
OR (95% CI)
OR (95% CI)
Independent risk factors of obstetric haemorrhage and C-statistics
Model 1* (n = 53,191):
Model 2**(n = 53,191):
Chronic renal diseases (yes)
Psychiatric disorders (yes)
Baby's gender (female)
Birth weight (per 100 g)
Multiple births (yes)
Preterm (20 - 36 weeks)
Term (37 - 41 weeks)
Postterm (≥42 weeks)
20 - 34 years
Onset of labor + mode of delivery
Elective CS^ (no labor)
Emergency CS + induction/augmentation
Instrumental + induction/augmentation
Vaginal + induction/augmentation
Emergency CS (spontaneous labor)
Instrumental (spontaneous labor)
Vaginal (spontaneous labor)
Type of hospital (tertiary vs. other)
C-statistic (95% CI)
C-statistic (95% CI)
P for comparing the two correlated C statistics: 0.61
This study showed that longer ascertainment periods resulted in improved identification of chronic disease history among pregnant women. Surprisingly, extension of the lookback period up to five years for chronic diseases did not increase the estimated risk effect of any predictions of haemorrhage, and contributed little to the performance of the haemorrhage predictive model. These results indicate that the effort of accessing previous hospital records for the completeness of comorbidity information is not always worthwhile.
As anticipated, the ascertainment rate of a chronic disease in this and other studies  increased progressively with increasing length of the lookback period. We hoped that a five-year ascertainment period for a chronic disease would give good estimation of the population prevalence in the study of young and generally healthy women. In this study, the population prevalence of chronic renal disease in young women in NSW was estimated to be around 0.7% based on a five-year ascertainment period. This is within the range of internationally reported prevalence (0.5 to 1.3%) [23–26]. The rate of 0.8% for cardiac diseases (mainly congenital heart disease in this population) in this study also appears to provide a good estimate of the population prevalence. Congenital heart disease occurs in approximately 1% of newborn babies worldwide  and about 80% of patients with such disease survive to adulthood . The prevalence of 0.6% for pre-existing diabetes in this study is similar to the population prevalence of 0.7% in Australian women aged <45 years, 2004 to 2005 . The rate of 0.51% for thyroid disorders in this study is similar to the estimated rate of clinical hypothyroidism or hyperthyroidism in the USA (0.43%), although the majority of thyroid disease is subclinical [30, 31].
However, our study indicated that the prevalence of some diseases (i.e. asthma and chronic hypertension) was under-estimated. This is likely to be related to the fact that hospital data only identifies diseases/conditions that require hospitalisation or that affect a hospital admission. Although lookback over 5 years increased the identification of asthma from 0.9% to 2.4%, this still represents poor identification of women with asthma. The National Health Survey 2004-05 reported that 13.5% of Australian women aged 15 to 45 years had asthma and 3% of the population had COPD (emphysema and/or bronchitis) . Similarly a validation study of 1184 pregnant women in NSW reported the prevalence of asthma to be 12% in pregnancy and the sensitivity of the recording of asthma as a comorbidity during maternal birth admissions was only 12.3% . The prevalence of chronic hypertension (1% with ≥2 years of lookback) is lower than the prevalence of antihypertensive drug use in 25 to 34 year olds in NSW in 1999 (1.4%), but 26.3% of pregnant women were < 25 years in our population . Other limitations of using longitudinally linked hospital records included missing ascertainment periods (e.g. migration or admission to hospitals outside NSW) and outpatient data, the assumption of disease chronicity and changes in diagnostic criteria for a disease over time.
With regard to predictive ability, information from prior hospital admissions might not improve the capacity of a predictive model if it were simply used to increase the number of cases with a condition. In a study of 61,815 patients, Kim and Ahn  reported no significant improvement in the predictive capacity of in-hospital mortality of a model with 3-years inpatient comorbidity score (either Elixhauser or Charlson) compared to a model with 1-year inpatient comorbidity score. Zhang et al.  also reported that models for 1-year mortality prediction among elderly patients using 1-year inpatient Charlson score or 2-years inpatient Charlson score were almost identical. Extra cases identified from prior admissions might be less severe or at an early stage of the illness but are treated equally to the cases from the index admission in the analysis. This might explain the finding of no improvement in the statistical performance by this and other studies.
On the other hand, Zhang et al.  found increased predictive capacity if comorbidity information from year 1 and year 2 inpatient records for the Charlson score were entered separately into the model. Preen et al.  reported similar findings, and found that C-statistics for 1-year mortality prediction in medical patients and procedural patients were 0.892 and 0.917 respectively for a model with a comorbidity score of the index admission and increased to 0.900 and 0.923 respectively for a model with two comorbidity scores: one for the index admission and another for 5-year prior admissions. In another study of the contribution to model performance in predicting in-hospital mortality made by extra information from a 3-year lookback period, Stukenborg et al.  reported that comorbidity risk adjustment (either Deyo/Charlson or Elixhauser method) achieved the best performance in various groups of hospital patients when comorbidity information from the index and prior admissions were treated as separate covariates in a model. Nevertheless, they also concluded that ascertaining information from prior admissions provided little improvement in the explanatory power of risk adjustment methods. Using information from the index and prior admissions as independent indicators might allow the model to distinguish late-stage from early-stage cases because more severe cases were more likely to be ascertained more than once and thus produce some improvement in the statistical performance.
With regard to effect estimation, increasing the number of cases with a disease/condition by using information from prior hospital admissions could produce an effect size smaller than that estimated using only the index record (i.e. only severe or active cases). In this study we found that the more remote (in time) that hospitalisations with chronic disease were reported, the smaller the effect the disease had on haemorrhage. One explanation for this could be that conditions that were ascertained from previous hospital records might have been treated and well controlled or be less severe than conditions identified from the index records. The effect of a risk factor on a particular outcome is likely to be dependent not only on the risk factor but also its severity, and a more severe instance is more likely to be ascertained in recent records than in older records . Not much additional comorbidity information had been gained in this generally young and healthy population using a longer lookback period. Thus, this study indicates that the findings of lookback studies may not be generalisable between young and older populations.
Chronic renal disease (via anemia) and psychiatric disorders (via medication) may place women at increased risk of obstetric haemorrhage . Pregnant women with chronic renal disease or treated psychiatric disorders which complicate the pregnancy or are associated with hospitalisation during the pregnancy should be considered to be at risk of haemorrhage and be treated accordingly.
A five-year ascertainment period for a chronic disease improves estimation of the population prevalence in a young and generally healthy population if the disease required treatment in hospital. On the other hand, diseases that do not require hospitalisation or cases with no obvious symptoms or in subclinical categories would usually not be picked up using longitudinally linked hospital records. In the case of haemorrhage prediction, comorbidity information from prior hospital admissions did little to improve the haemorrhage modelling. For estimating the effect size of a risk factor, the most appropriate lookback period should be determined by the study objective.
We thank the NSW Department of Health for access to the population health data and the NSW Centre for Health Record Linkage for linking the data sets. Funding for this project was provided by the Outcomes, Services and Policy for the Reproductive and Early Years, a population health capacity building grant from the Australian National Health and Medical Research Council (NHMRC). JSC and JBF are supported by the NHMRC Capacity Building Grant. The NHMRC supports CLR with a Senior Research Fellowship.
- Jencks SF, Williams DK, Kay TL: Assessing hospital-associated deaths from discharge data. The role of length of stay and comorbidities. JAMA. 1988, 260: 2240-2246. 10.1001/jama.260.15.2240.View ArticlePubMedGoogle Scholar
- Iezzoni LI, Foley SM, Daley J, Hughes J, Fisher ES, Heeren T: Comorbidities, complications, and coding bias. Does the number of diagnosis codes matter in predicting in-hospital mortality?. JAMA. 1992, 267: 2197-2203. 10.1001/jama.267.16.2197.View ArticlePubMedGoogle Scholar
- Zhang JX, Iwashyna TJ, Christakis NA: The performance of different lookback periods and sources of information for Charlson comorbidity adjustment in Medicare claims. Med Care. 1999, 37: 1128-1139. 10.1097/00005650-199911000-00005.View ArticlePubMedGoogle Scholar
- Shack LG, Rachet B, Williams EM, Northover JM, Coleman MP: Does the timing of comorbidity affect colorectal cancer survival? A population based study. Postgrad Med J. 2010, 86: 73-78. 10.1136/pgmj.2009.084566.View ArticlePubMedGoogle Scholar
- Kim KH, Ahn LS: A comparative study on comorbidity measurements with lookback period using health insurance database: focused on patients who underwent percutaneous coronary intervention. J Prev Med Public Health. 2009, 42: 267-273. 10.3961/jpmph.2009.42.4.267.View ArticlePubMedGoogle Scholar
- Preen DB, Holman CD, Spilsbury K, Semmens JB, Brameld KJ: Length of comorbidity lookback period affected regression model performance of administrative health data. J Clin Epidemiol. 2006, 59: 940-946. 10.1016/j.jclinepi.2005.12.013.View ArticlePubMedGoogle Scholar
- Sarfati D, Hill S, Purdie G, Dennett E, Blakely T: How well does routine hospitalisation data capture information on comorbidity in New Zealand?. N Z Med J. 2010, 123: 50-61.PubMedGoogle Scholar
- Stukenborg GJ, Wagner DP, Connors AF: Comparison of the performance of two comorbidity measures, with and without information from prior hospitalizations. Medical Care. 2001, 39: 727-739. 10.1097/00005650-200107000-00009.View ArticlePubMedGoogle Scholar
- World Health Organization: The World Health Report 2005 - make every mother and child count. [http://www.who.int/whr/2005/en/index.html]
- Knight M, Callaghan WM, Berg C, Alexander S, Bouvier-Colle MH, Ford JB, Joseph KS, Lewis G, Liston RM, Roberts CL, Oats J, Walker J: Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the International Postpartum Hemorrhage Collaborative Group. BMC Pregnancy Childbirth. 2009, 9: 55-10.1186/1471-2393-9-55.View ArticlePubMedPubMed CentralGoogle Scholar
- Ford JB, Roberts CL, Simpson JM, Vaughan J, Cameron CA: Increased postpartum hemorrhage rates in Australia. Int J Gynaecol Obstet. 2007, 98: 237-243. 10.1016/j.ijgo.2007.03.011.View ArticlePubMedGoogle Scholar
- Stones RW, Paterson CM, Saunders NJ: Risk factors for major obstetric haemorrhage. Eur J Obstet Gynecol Reprod Biol. 1993, 48: 15-18. 10.1016/0028-2243(93)90047-G.View ArticlePubMedGoogle Scholar
- Sosa CG, Althabe F, Belizan JM, Buekens P: Risk factors for postpartum hemorrhage in vaginal deliveries in a Latin-American population. Obstet Gynecol. 2009, 113: 1313-1319.View ArticlePubMedPubMed CentralGoogle Scholar
- Chen JS, Roberts CL, Ford JB, Taylor LK, Simpson JM: Cross-sectional reporting of previous cesarean birth was validated using longitudinal linked data. J Clin Epidemiol. 2010, 63: 672-678. 10.1016/j.jclinepi.2009.08.019.View ArticlePubMedGoogle Scholar
- National Centre for Classification in Health: Australian Coding standards for ICD-10-AM and ACHI. National Centre for Classification in Health, University of Sydney, Sydney. 2004Google Scholar
- Alexander S, Dodds L, Armson BA: Perinatal outcomes in women with asthma during pregnancy. Obstet Gynecol. 1998, 92: 435-440. 10.1016/S0029-7844(98)00191-4.PubMedGoogle Scholar
- Davis LE, Leveno KJ, Cunningham FG: Hypothyroidism complicating pregnancy. Obstet Gynecol. 1988, 72: 108-112.PubMedGoogle Scholar
- Siu SC, Sermer M, Harrison DA, Grigoriadis E, Liu G, Sorensen S, Smallhorn JF, Farine D, Amankwah KS, Spears JC, Colman JM: Risk and predictors for pregnancy-related complications in women with heart disease. Circulation. 1997, 96: 2789-2794.View ArticlePubMedGoogle Scholar
- Roberts CL, Bell JC, Ford JB, Hadfield RM, Algert CS, Morris JM: The accuracy of reporting of the hypertensive disorders of pregnancy in population health data. Hypertens Pregnancy. 2008, 27: 285-297. 10.1080/10641950701826695.View ArticlePubMedPubMed CentralGoogle Scholar
- Taylor LK, Travis S, Pym M, Olive E, Henderson-Smart DJ: How useful are hospital morbidity data for monitoring conditions occurring in the perinatal period?. Aust N Z J Obstet Gynaecol. 2005, 45: 36-41. 10.1111/j.1479-828X.2005.00339.x.View ArticlePubMedGoogle Scholar
- SAS Institute: Nonparametric comparison of areas under correlated ROC curves. [http://support.sas.com/kb/25/017.html]
- DeLong ER, DeLong DM, Clarke-Pearson DL: Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988, 44: 837-845. 10.2307/2531595.View ArticlePubMedGoogle Scholar
- Cirillo M, Laurenzi M, Mancini M, Zanchetti A, Lombardi C, De Santo NG: Low glomerular filtration in the population: prevalence, associated disorders, and awareness. Kidney Int. 2006, 70: 800-806. 10.1038/sj.ki.5001641.View ArticlePubMedGoogle Scholar
- Li ZY, Xu GB, Xia TA, Wang HY: Prevalence of chronic kidney disease in a middle and old-aged population of Beijing. Clin Chim Acta. 2006, 366: 209-215. 10.1016/j.cca.2005.10.011.View ArticlePubMedGoogle Scholar
- Coresh J, Byrd-Holt D, Astor BC, Briggs JP, Eggers PW, Lacher DA, Hostetter TH: Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol. 2005, 16: 180-188.View ArticlePubMedGoogle Scholar
- Zhang QL, Rothenbacher D: Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health. 2008, 8: 117-10.1186/1471-2458-8-117.View ArticlePubMedPubMed CentralGoogle Scholar
- Gatzoulis MA, Swan L, Therrien J, Pantley GA: Adult Congenital Heart Disease: A Practical Guide. 2005, Blackwell Publishing Ltd. LondonView ArticleGoogle Scholar
- Nieminen HP, Jokinen EV, Sairanen HI: Late results of pediatric cardiac surgery in Finland: a population-based study with 96% follow-up. Circulation. 2001, 104: 570-575. 10.1161/hc3101.093968.View ArticlePubMedGoogle Scholar
- Australian Institute of Health and Welfare: Diabetes prevalence in Australia: An assessment of national data sources. Cat. no. CVD 46. 2009, CanberraGoogle Scholar
- Aoki Y, Belin RM, Clickner R, Jeffries R, Phillips L, Mahaffey KR: Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002). Thyroid. 2007, 17: 1211-1223. 10.1089/thy.2006.0235.View ArticlePubMedGoogle Scholar
- Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE: Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002, 87: 489-499. 10.1210/jc.87.2.489.View ArticlePubMedGoogle Scholar
- The Australian Institute of Health and Welfare: Australia's health 2008. Cat. no. AUS 99. 2008, CanberraGoogle Scholar
- Hadfield RM, Lain SJ, Cameron CA, Bell JC, Morris JM, Roberts CL: The prevalence of maternal medical conditions during pregnancy and a validation of their reporting in hospital discharge data. Aust N Z J Obstet Gynaecol. 2008, 48: 78-82. 10.1111/j.1479-828X.2007.00818.x.View ArticlePubMedGoogle Scholar
- Barr E, Cameron A, Shaw J, Zimmet P: The Australian Diabetes Obesity and Lifestyle Study (AusDiab): Five year follow-up Results for New South Wales. 2005, [http://www.health.nsw.gov.au/resources/publichealth/surveys/au_diab_obes.pdf]Google Scholar
- Donaghy M, Chang CL, Poulter N: Duration, frequency, recency, and type of migraine and the risk of ischaemic stroke in women of childbearing age. J Neurol Neurosurg Psychiatry. 2002, 73: 747-750. 10.1136/jnnp.73.6.747.View ArticlePubMedPubMed CentralGoogle Scholar
- Salkeld E, Ferris LE, Juurlink DN: The risk of postpartum hemorrhage with selective serotonin reuptake inhibitors and other antidepressants. J Clin Psychopharmacol. 2008, 28: 230-234. 10.1097/JCP.0b013e318166c52e.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2288/11/68/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.